Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States

JAMA Intern Med. 2021 Jul 1;181(7):995-997. doi: 10.1001/jamainternmed.2021.0484.

Authors

Bryan S Walsh¹, Ameet Sarpatwari¹, Benjamin N Rome¹, Aaron S Kesselheim¹

Affiliation

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Abstract

This cohort study assessed the frequency of approvals of first generic drugs with skinny labels in the US.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Approval*
Drug Labeling*
Drugs, Generic*
Humans
United States
United States Food and Drug Administration

Substances

Drugs, Generic